The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Successful treatment of recurrent follicular B-cell lymphoma with clarithromycin, prednisolone, and cyclophosphamide

  • Ohe, Masashi (Department of General Medicine, Hokkaido Social Insurance Hospital) ;
  • Hashino, Satoshi (Department of Gastroenterology and Hematology, Hokkaido University Graduate School of Medicine)
  • Published : 2013.05.01
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Govi S, Dognini GP, Licata G, et al. Six-month oral clarithromycin regimen is safe and active in extranodal marginal zone B-cell lymphomas: f inal results of a single-centre phase II trial. Br J Haematol 2010;150:226-229.
  2. Ishimatsu Y, Mukae H, Matsumoto K, et al. Two cases with pulmonary mucosa-associated lymphoid tissue lymphoma successfully treated with clarithromycin. Chest 2010;138:730-733. https://doi.org/10.1378/chest.09-2358
  3. Ohe M, Hashino S. A case of follicular B-cell lymphoma treated using clarithromycin. Korean J Hematol 2011;46:203-206. https://doi.org/10.5045/kjh.2011.46.3.203
  4. Ohe M, Hashino S, Hattori A. Successful treatment of diffuse large B-cell lymphoma with clarithromycin and prednisolone. Korean J Hematol 2012;47:293-297. https://doi.org/10.5045/kjh.2012.47.4.293
  5. Ohara T, Morishita T, Suzuki H, Masaoka T, Ishii H, Hibi T. Antibiotics directly induce apoptosis in B cell lymphoma cells derived from BALB/c mice. Anticancer Res 2004;24:3723-3730.

Cited by

  1. Clarithromycin/cyclophosphamide/prednisolone : Acute pneumonia and thrombocytopenia: case report vol.1459, pp.1, 2013, https://doi.org/10.1007/s40278-013-4251-y
  2. Repurposing Drugs in Oncology (ReDO)—clarithromycin as an anti-cancer agent vol.9, pp.None, 2013, https://doi.org/10.3332/ecancer.2015.513
  3. Primary Pulmonary Hodgkin Lymphoma Associated with Primary Sjögren's Syndrome vol.39, pp.3, 2013, https://doi.org/10.12771/emj.2016.39.3.95